Common Myeloid Progenitors As Biomarkers of Hbf Response to Hydroxyurea in Sickle Cell Disease

被引：0

作者：

Minniti, Caterina P. ^{[1
]}

Tolu, Seda S. ^{[2
]}

Wang, Kai ^{[3
]}

Yan, Zi ^{[4
]}

Crouch, Andrew ^{[2
]}

Sebastian, Gracy ^{[5
]}

Chaitowitz, Mark ^{[6
]}

Schwechter, Evan ^{[7
]}

Uehlinger, Joan ^{[7
]}

Manwani, Deepa ^{[8
]}

Fornari, Eric ^{[7
]}

Bouhassira, Eric E. ^{[9
]}

机构：

[1] Montefiore Med Ctr, Albert Einstein Coll Med, Div Hematol, Bronx, NY 10467 USA

[2] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA

[3] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA

[4] Albert Einstein Coll Med, Bronx, NY 10467 USA

[5] Montefiore Med Ctr, Sickle Cell Ctr, 111 E 210th St, Bronx, NY 10467 USA

[6] Montefiore Med Ctr, New York, NY USA

[7] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA

[8] Childrens Hosp Montefiore, Bronx, NY USA

[9] Albert Einstein Coll Med, Div Hem & Cell Bio, Bronx, NY 10467 USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-131466

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4827

引用

页数：3

共 50 条

[21] ERYTHROPOIESIS RESPONSE MARKERS TO HYDROXYUREA THERAPY IN PATIENTS WITH SICKLE CELL DISEASE
Chalvatzi, K.
Nikolaidou, A.
Pantelidou, D.
Chalkia, P.
Diza, E.
HAEMATOLOGICA, 2012, 97 : 704 - 705
[22] Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model
Lebensburger, Jeffrey D.
Pestina, Tamara I.
Ware, Russell E.
Boyd, Kelli L.
Persons, Derek A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1599 - 1603
[23] Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease
Saber, Christine
Madhukar, Rashmi
Oluwole, Olubusola
Decastro, Laura M.
Novelli, Enrico M.
Xu, Julia
BLOOD, 2023, 142
[24] Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease
Steinberg, MH
Voskaridou, E
Kutlar, A
Loukopoulos, D
Koshy, M
Ballas, SK
Castro, O
Barton, F
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (02) : 121 - 126
[25] Hydroxyurea Therapy Requires HbF Induction for Clinical Benefit in a Sickle Cell Mouse Model
Lebensburger, Jeffrey D.
Pestina, Tamara I.
Boyd, Kelli
Ware, Russell E.
Persons, Derek
BLOOD, 2009, 114 (22) : 337 - 337
[26] Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient
Regan, Samuel
Yang, Xuebin
Finnberg, Niklas K.
El-Deiry, Wafik S.
Pu, Jeffrey J.
CANCER BIOLOGY & THERAPY, 2019, 20 (11) : 1389 - 1397
[27] A Genetic Predictive Model for HbF in Sickle Cell Disease
Gardner, Kate
Fulford, Tony
Rooks, Helen
Silver, Nick
Howard, Jo
Awogbade, Moji
Stuart-Smith, Sara
Yeghen, Tullie
Menzel, Stephan
Thein, Swee Lay
BLOOD, 2016, 128 (22)
[28] Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors
Baliga, BS
Pace, BS
Chen, HH
Shah, AK
Yang, YM
AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (03) : 227 - 233
[29] Hydroxyurea Adherence By Personal Best HbF and the 2-Site "HABIT" Intervention Trial for Pediatric Sickle Cell Disease
Green, Nancy S.
Manwani, Deepa
Soto, Luisa
Karen, Ireland
Castillo, Yina
Smaldone, Arlene M.
BLOOD, 2014, 124 (21)
[30] Protective Effects of HbF on Mortality in Sickle Cell Disease
Mitelman, Olga
Barry, Jonathan
Bernhard, Jonathan
Bruno, Paul
Snedecor, Sonya J.
Ronnebaum, Sarah
Allen, Geoffrey A.
Morabito, Christopher
BLOOD, 2022, 140 : 11118 - 11119

← 1 2 3 4 5 →